Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Widening the mutation spectrum of EVC and EVC2: Ectopic expression of Weyer variants in NIH 3T3 fibroblasts disrupts hedgehog signaling
Human Mutation, Volume 30, No. 12, Year 2009
Notification
URL copied to clipboard!
Description
Autosomal recessive Ellis-van Creveld syndrome and autosomal dominant Weyer acrodental dysostosis are allelic conditions caused by mutations in EVC or EVC2.We performed a mutation screening study in 36 EvC cases and 3 cases of Weyer acrodental dysostosis, and identified pathogenic changes either in EVC or in EVC2 in all cases. We detected 40 independent EVC/EVC2 mutations of which 29 were novel changes in Ellis-van Creveld cases and 2 were novel mutations identified in Weyer pedigrees. Of interest one EvC patient had a T > G nucleotide substitution in intron 7 of EVC (c.940-150T4G), which creates a new donor splice site and results in the inclusion of a new exon. The T > G substitution is at nucleotide 15 of the novel 5′ splice site. The three Weyer mutations occurred in the final exon of EVC2 (exon 22), suggesting that specific residues encoded by this exon are a key part of the protein. Using murine versions of EVC2 exon 22 mutations we demonstrate that the expression of a Weyer variant, but not the expression of a truncated protein that mimics an Ellis-van Creveld syndrome mutation, impairs Hedgehog signal transduction in NIH 3T3 cells in keeping with its dominant effect. © 2009 Wiley-Liss, Inc.
Authors & Co-Authors
Valencia, Maria
Spain, Madrid
Consejo Superior de Investigaciones Científicas
Lapunzina-Badía, Pablo Daniel
Spain, Madrid
Hospital Universitario la Paz
Lim, Derek
United Kingdom, Birmingham
Birmingham Women's Hospital
Zannolli, Raffaella
Italy, Siena
Azienda Ospedaliera Universitaria Senese
Bartholdi, Deborah
Switzerland, Zurich
Universität Zürich
Wollnik, Bernd
Germany, Koln
Universität zu Köln
Al-Ajlouni, Othman
Jordan, Amman
King Hussein Medical Center, Amman
Eid, Suhair S.
Jordan, Amman
King Hussein Medical Center, Amman
Cox, Helen
United Kingdom, Birmingham
Birmingham Women's Hospital
Buoni, Sabrina
Italy, Siena
Azienda Ospedaliera Universitaria Senese
Hayek, Joseph
Italy, Siena
Azienda Ospedaliera Universitaria Senese
Martinez-Frias, Maria L.
Spain, Madrid
Instituto de Salud Carlos Iii
Antonio, Perez Aytes
Spain, Valencia
Hospital Universitari I Politècnic la fe
Temtamy, Samia Ali Li
Egypt, Giza
National Research Centre
Aglan, Mona Sabry
Egypt, Giza
National Research Centre
Goodship, Judith A.
United Kingdom, Newcastle
Newcastle University
Ruiz-Perez, Victor L.
Spain, Madrid
Consejo Superior de Investigaciones Científicas
Statistics
Citations: 57
Authors: 17
Affiliations: 11
Identifiers
Doi:
10.1002/humu.21117
ISSN:
10597794
Research Areas
Cancer
Genetics And Genomics
Health System And Policy